Camila Vidal

QA - Regulatory Affairs Coordinator at Grünenthal Group - Worthington, IA, US

Camila Vidal's Colleagues at Grünenthal Group
Barbara Brunnsteiner-Kruger

MSL (Medical Science Liaison) & Market Access Manager

Contact Barbara Brunnsteiner-Kruger

Martha Bernal

Representante médico

Contact Martha Bernal

Manuel Keller

Commercial Opportunity & Project Manager

Contact Manuel Keller

Carla Molina

Analista de investigación y desarrollo

Contact Carla Molina

View All Camila Vidal's Colleagues
Camila Vidal's Contact Details
HQ
49-241-569-0
Location
Ñuñoa,Santiago Metropolitan Region,Chile
Company
Grünenthal Group
Camila Vidal's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about Camila Vidal
Camila Vidal currently works for Grünenthal Group.
Camila Vidal's role at Grünenthal Group is QA - Regulatory Affairs Coordinator.
Camila Vidal's email address is ***@grunenthal.com. To view Camila Vidal's full email address, please signup to ConnectPlex.
Camila Vidal works in the Pharmaceuticals industry.
Camila Vidal's colleagues at Grünenthal Group are Barbara Brunnsteiner-Kruger, Martha Bernal, Alex Aranibar, Manuel Keller, Carla Molina, Leandro Savoia, Claudio Tapia and others.
Camila Vidal's phone number is 49-241-569-0
See more information about Camila Vidal